Development of an efficient and scalable method for processing and purification of Vi capsular polysaccharide

Procedia in Vaccinology

Volumn 2, Issue 1, 2010, Pages 78-81

  Kothari, Sudeep ^a   Kothari, Neha ^a   Lee, Eugene ^a   Kim, Jeong Ah ^a   An, So Jung ^a   Yoon, Yeon Kyung ^a   Smith, Greg W ^a   Carbis, Rodney ^a  

^a International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMMONIUM SULFATE; BACTERIAL POLYSACCHARIDE; CETRIMIDE; LIPOPOLYSACCHARIDE; NUCLEIC ACID; PROTEIN; SODIUM CHLORIDE; TYPHOID VACCINE; UNCLASSIFIED DRUG; VI CAPSULAR POLYSACCHARIDE; WATER;

CARBOHYDRATE SYNTHESIS; CONFERENCE PAPER; CROSSFLOW FILTRATION; DIAFILTRATION; DRUG COST; FERMENTATION; NONHUMAN; PH; PRECIPITATION; PRIORITY JOURNAL; PROCESSING; PURIFICATION; SALMONELLA TYPHI; TYPHOID FEVER; VACCINE PRODUCTION;

EID: 77950574344     PISSN: 1877282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.provac.2010.03.014     Document Type: Conference Paper

References (9)

1. World Health Organization. Typhoid vaccine: Who position paper. Wkl Epidemil Rec 75 (2000) 257-264
2. Crump J.A., Luby S.P., and Mintz E.D. The global burden of typhoid fever. Bull WHO 82 5 (2004) 346-353
3. L. Kenne, and B. Lindberg 1983. Bacterial polysaccharides, in The Polysaccharides, vol. 2 G. Aspinall (ed.), Academic Press, inc., NewYork, N.Y. p. 315.
4. Robbins J.D., and Robbins J.B. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J. Infect. Dis. 150 3 (1984) 436-449
5. Szu S.C., Li X.R., Schneerson R., Vickers J.H., Bryla D., and Robbins J.B. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi. Infect. Immun. 57 12 (1989) 3823-3827
6. Szewczyk B., and Taylor A. Immunochemical properties of Vi antigen from salmonella typhi Ty2: presence of two antigenic determinants. Infect. Immun. 29 2 (1980) 539-544
7. Tacket C.O., Levine M.M., and Robbins J.B. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever. Vaccine 6 4 (1988) 307-308
8. Jang H., Yoon Y.K., Kim J.A., Kim H.S., An S.J., Seo J.H., Cui C., and Carbis R. Optimization of Vi capsular polysaccharide production during growth of Salmonella enterica serotype Typhi Ty2 in a bioreactor. J. Biotechnol. 135 (2008) 71-77
9. WHO Expert Committee on Biological Standardization. 1994. WHO Technical Report Series, No 840.